The TED website is eForms-ready since 2.11.2022. The search changed: please adapt your predefined expert queries. Discover the changes in the site news and in the updated Help Pages
EU solidarity with Ukraine
Prozorro+: Ukrainian public procurement platform
Belgium-Brussels: Ex Post Evaluation: EU Competition Enforcement and Acquisitions of Innovative Competitors in the Pharma Sector Leading to the Discontinuation of Overlapping Drug Research and Development Projects
Section I: Contracting authority
Section II: Object
Ex Post Evaluation: EU Competition Enforcement and Acquisitions of Innovative Competitors in the Pharma Sector Leading to the Discontinuation of Overlapping Drug Research and Development Projects
Empirical research by Cunningham et al. (2021) suggests that in the pharmaceutical industry a considerable number of acquisitions might have as their object or effect the discontinuation of overlapping drug R&D projects to the detriment of innovation competition and ultimately consumers. Such acquisitions are commonly referred to as ‘killer acquisitions’. The study aims to determine what are the typical features of such killer acquisitions and obtain evidence on the prevalence of such acquisitions, as this would allow the Commission to determine which transactions in the pharmaceutical industry deserve closer scrutiny. A second objective of the study is to conduct ex post evaluations of selected past merger decisions. These case studies aim to assess whether in the concentrations notified to and examined by the Commission under the EU Merger Regulation, the Commission correctly anticipated the risks of possible discontinuations of competing lines of drug R&D projects.
Please consult the procurement documents available at the address indicated in section I.3).
Ex post evaluation: EU competition enforcement and acquisitions of innovative competitors in the pharma sector leading to the discontinuation of overlapping drug research and development projects.
Single market programme.
Section III: Legal, economic, financial and technical information
Section IV: Procedure
European Commission, DG Competition, Place Madou 1, Brussels.
Please note that, given the current circumstances, the opening might be done by videoconference.
Section VI: Complementary information
Please consult the procurement documents available at the address indicated in section I.3). In case of unavailability or disruptions in the functioning of the electronic means of communication provided in section I.3) in the last five calendar days before the time limit for receipt indicated in section IV.2.2), the contracting authority reserves the right to extend this time limit and publish the extension at the Internet address provided in section I.3), without a preceding publication of a corrigendum to this notice. Economic operators interested in this procurement are invited to subscribe to the call for tenders at the address in section I.3) in order to get notified when new information or documents are published.